Louis Boon

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Low Density Lipoprotein

Histone Deacetylase

Peripheral Blood

Immune Response

Top Venues

Science immunology

Science advances

Arteriosclerosis, thrombosis, and vascular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Sarah Schäfer, Rajinikanth Gogiraju, Melanie Rösch, Yvonne Kerstan, Lina Beck, Janine Garbisch, Antoine-Emmanuel Saliba, Anton Gisterå, Heike M Hermanns, Louis Boon, Wolfgang Kastenmüller, Katrin Schäfer, Clément Cochain, Alma Zernecke
CD8 + T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Sarah Schäfer, Rajinikanth Gogiraju, Melanie Rösch, Yvonne Kerstan, Lina Beck, Janine Garbisch, Antoine-Emmanuel Saliba, Anton Gisterå, Heike M Hermanns, Louis Boon, Wolfgang Kastenmüller, Katrin Schäfer, Clément Cochain, Alma Zernecke
CD8 + T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Sarah Schäfer, Rajinikanth Gogiraju, Melanie Rösch, Yvonne Kerstan, Lina Beck, Janine Garbisch, Antoine-Emmanuel Saliba, Anton Gisterå, Heike M Hermanns, Louis Boon, Wolfgang Kastenmüller, Katrin Schäfer, Clément Cochain, Alma Zernecke
CD8 + T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 44 (8) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Sarah Schäfer, Rajinikanth Gogiraju, Melanie Rösch, Yvonne Kerstan, Lina Beck, Janine Garbisch, Antoine-Emmanuel Saliba, Anton Gisterå, Heike M Hermanns, Louis Boon, Wolfgang Kastenmüller, Katrin Schäfer, Clément Cochain, Alma Zernecke
CD8 + T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology (2024)
Sebastian Ochoa, Amy P Hsu, Andrew J Oler, Dhaneshwar Kumar, Daniel Chauss, Jan Piet van Hamburg, Gustaaf G van Laar, Vasileios Oikonomou, Sundar Ganesan, Elise M N Ferré, Monica M Schmitt, Thomas DiMaggio, Princess Barber, Gregory M Constantine, Lindsey B Rosen, Paul G Auwaerter, Bhumika Gandhi, Jennifer L Miller, Rachel Eisenberg, Arye Rubinstein, Edith Schussler, Erjola Balliu, Vandana Shashi, Marta Aboza Garcia, Peter Olbrich, Kim My Le, Nanni Mamia, Saila Laakso, Pasi I Nevalainen, Juha Grönholm, Mikko R J Seppänen, Louis Boon, Gulbu Uzel, Luis Miguel Franco, Theo Heller, Karen K Winer, Rajarshi Ghosh, Bryce A Seifert, Magdalena Walkiewicz, Luigi Daniele Notarangelo, Qing Zhou, Ivona Aksentijevich, William A Gahl, Cliffton L Dalgard, Lalith Perera, Behdad Afzali, Sander W Tas, Steven M Holland, Michail S Lionakis
A deep intronic splice-altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion. Science translational medicine 16 (765) (2024)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Victor Bosteels, Sandra Maréchal, Clint De Nolf, Sofie Rennen, Jonathan Maelfait, Simon J Tavernier, Jessica Vetters, Evelien Van De Velde, Farzaneh Fayazpour, Kim Deswarte, Alexander Lamoot, Julie Van Duyse, Liesbet Martens, Cedric Bosteels, Ria Roelandt, Annelies Emmaneel, Sofie Van Gassen, Louis Boon, Gert Van Isterdael, Isabelle Guillas, Niels Vandamme, Doris Höglinger, Bruno G De Geest, Wilfried Le Goff, Yvan Saeys, Kodi S Ravichandran, Bart N Lambrecht, Sophie Janssens
LXR signaling controls homeostatic dendritic cell maturation. Science immunology 8 (83) (2023)
Junjie Ma, Egon Urgard, Solveig Runge, Cajsa Helena Classon, Laura Mathä, Julian M Stark, Liqin Cheng, Javiera A Álvarez, Silvia von Zedtwitz, Austeja Baleviciute, Sergio Martinez Hoyer, Muzhen Li, Anne Marleen Gernand, Lisa Osbelt, Agata Anna Bielecka, Till Robin Lesker, Huey-Jy Huang, Susanne Vrtala, Louis Boon, Rudi Beyaert, Mikael Adner, Itziar Martinez-Gonzalez, Till Strowig, Juan Du, Susanne Nylén, Stephan P Rosshart, Jonathan M Coquet
Laboratory mice with a wild microbiota generate strong allergic immune responses. Science immunology 8 (87) (2023)
Victor Bosteels, Sandra Maréchal, Clint De Nolf, Sofie Rennen, Jonathan Maelfait, Simon J Tavernier, Jessica Vetters, Evelien Van De Velde, Farzaneh Fayazpour, Kim Deswarte, Alexander Lamoot, Julie Van Duyse, Liesbet Martens, Cedric Bosteels, Ria Roelandt, Annelies Emmaneel, Sofie Van Gassen, Louis Boon, Gert Van Isterdael, Isabelle Guillas, Niels Vandamme, Doris Höglinger, Bruno G De Geest, Wilfried Le Goff, Yvan Saeys, Kodi S Ravichandran, Bart N Lambrecht, Sophie Janssens
LXR signaling controls homeostatic dendritic cell maturation. Science immunology 8 (83) (2023)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Victor Bosteels, Sandra Maréchal, Clint De Nolf, Sofie Rennen, Jonathan Maelfait, Simon J Tavernier, Jessica Vetters, Evelien Van De Velde, Farzaneh Fayazpour, Kim Deswarte, Alexander Lamoot, Julie Van Duyse, Liesbet Martens, Cedric Bosteels, Ria Roelandt, Annelies Emmaneel, Sofie Van Gassen, Louis Boon, Gert Van Isterdael, Isabelle Guillas, Niels Vandamme, Doris Höglinger, Bruno G De Geest, Wilfried Le Goff, Yvan Saeys, Kodi S Ravichandran, Bart N Lambrecht, Sophie Janssens
LXR signaling controls homeostatic dendritic cell maturation. Science immunology 8 (83) (2023)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Anne-Charlotte Jonckheere, Brecht Steelant, Sven F Seys, Jonathan Cremer, Ellen Dilissen, Louis Boon, Adrian Liston, Rik Schrijvers, Christine Breynaert, Jeroen A J Vanoirbeek, Jan L Ceuppens, Dominique M A Bullens
Peribronchial Inflammation Resulting from Regulatory T Cell Deficiency Damages the Respiratory Epithelium and Disturbs Barrier Function. Journal of immunology (Baltimore, Md. : 1950) 209 (8) (2022)
Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M Arnouk, Ahmed E I Hamouda, Ayla Debraekeleer, Victor Bosteels, Yvon Elkrim, Louis Boon, Sabine Hoves, Niels Vandamme, Sofie Deschoemaeker, Sophie Janssens, Abhishek Dinkarnath Garg, Greetje Vande Velde, Martina Schmittnaegel, Carola H Ries, Damya Laoui
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages. Cancer research 82 (20) (2022)
Ashleigh R Poh, Christopher G Love, David Chisanga, James H Steer, David Baloyan, Michaël Chopin, Stephen L Nutt, Jai Rautela, Nicholas D Huntington, Nima Etemadi, Megan O'Brien, Ryan N O'Keefe, Lesley G Ellies, Christophe Macri, Justine D Mintern, Lachlan W Whitehead, Gangadhara Gangadhara, Louis Boon, Ashwini L Chand, Clifford A Lowell, Wei Shi, Fiona J Pixley, Matthias Ernst
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Science advances 8 (25) (2022)
Alex KleinJan, Menno van Nimwegen, Karolina Leman, Ke-Xin Wen, Louis Boon, Rudi W Hendriks
Involvement of Dendritic Cells and Th17 Cells in Induced Tertiary Lymphoid Structures in a Chronic Beryllium Disease Mouse Model. Mediators of inflammation 2021 (2021)
Brecht Creyns, Jonathan Cremer, Gert De Hertogh, Louis Boon, Marc Ferrante, Severine Vermeire, Gert Van Assche, Jan L Ceuppens, Christine Breynaert
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells. Immunity, inflammation and disease 8 (3) (2020)
Jiaxin Lin, Louis Boon, Robert Bockermann, Anna-Karin Robertson, Christian Kjellman, Colin C Anderson
Desensitization using imlifidase and EndoS enables chimerism induction in allosensitized recipient mice. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (9) (2020)
Renske J E van den Bijgaart, Michiel Kroesen, Ingrid C Brok, Daphne Reijnen, Melissa Wassink, Louis Boon, Peter M Hoogerbrugge, Gosse J Adema
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model. Oncoimmunology 9 (1) (2020)
Rachael M Zemek, Emma De Jong, Wee Loong Chin, Iona S Schuster, Vanessa S Fear, Thomas H Casey, Cath Forbes, Sarah J Dart, Connull Leslie, Ayham Zaitouny, Michael Small, Louis Boon, Alistair R R Forrest, Daithi O Muiri, Mariapia A Degli-Esposti, Michael J Millward, Anna K Nowak, Timo Lassmann, Anthony Bosco, Richard A Lake, Willem Joost Lesterhuis
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment. Science translational medicine 11 (501) (2020)
Jessica Vetters, Mary J van Helden, Sigrid Wahlen, Simon J Tavernier, Arne Martens, Farzaneh Fayazpour, Karl Vergote, Manon Vanheerswynghels, Kim Deswarte, Justine Van Moorleghem, Sofie De Prijck, Nozomi Takahashi, Peter Vandenabeele, Louis Boon, Geert van Loo, Éric Vivier, Bart N Lambrecht, Sophie Janssens
The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF. The Journal of experimental medicine 216 (9) (2019)
Shaokang Ma, Jonathan Chee, Vanessa S Fear, Catherine A Forbes, Louis Boon, Ian M Dick, Bruce W S Robinson, Jenette Creaney
Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome. Oncoimmunology 9 (1) (2019)
Wayne J Aston, Danika E Hope, Alistair M Cook, Louis Boon, Ian M Dick, Anna K Nowak, Richard A Lake, Willem Joost Lesterhuis
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment. Oncoimmunology 8 (11) (2019)